Literature DB >> 31707075

In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites.

Chantal D Bader1, Fabian Panter1, Rolf Müller2.   

Abstract

In recognition of many microorganisms ability to produce a variety of secondary metabolites in parallel, Zeeck and coworkers introduced the term "OSMAC" (one strain many compounds) around the turn of the century. Since then, additional efforts focused on the systematic characterization of a single bacterial species ability to form multiple secondary metabolite scaffolds. With the beginning of the genomic era mainly initiated by a dramatic reduction of sequencing costs, investigations of the genome encoded biosynthetic potential and especially the exploitation of biosynthetic gene clusters of undefined function gained attention. This was seen as a novel means to extend range and diversity of bacterial secondary metabolites. Genome analyses showed that even for well-studied bacterial strains, like the myxobacterium Myxococcus xanthus DK1622, many biosynthetic gene clusters are not yet assigned to their corresponding hypothetical secondary metabolites. In contrast to the results from emerging genome and metabolome mining techniques that show the large untapped biosynthetic potential per strain, many newly isolated bacterial species are still used for the isolation of only one target compound class and successively abandoned in the sense that no follow up studies are published from the same species. This work provides an overview about myxobacterial bacterial strains, from which not just one but multiple different secondary metabolite classes were successfully isolated. The underlying methods used for strain prioritization and natural product discovery such as biological characterization of crude extracts against a panel of pathogens, in-silico prediction of secondary metabolite abundance from genome data and state of the art instrumental analytics required for new natural product scaffold discovery in comparative settings are summarized and classified according to their output. Furthermore, for each approach selected studies performed with actinobacteria are shown to underline especially innovative methods used for natural product discovery.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Actinobacteria; Bioactivity-guided isolation; Genome mining; Genomics; Myxobacteria; Natural products; Secondary metabolites; Secondary metabolomics

Year:  2019        PMID: 31707075     DOI: 10.1016/j.biotechadv.2019.107480

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  12 in total

Review 1.  Myxobacteria and their products: current trends and future perspectives in industrial applications.

Authors:  Akansha Shrivastava; Rakesh Kumar Sharma
Journal:  Folia Microbiol (Praha)       Date:  2021-05-31       Impact factor: 2.099

2.  Isolation of Nannocystis species from Iran and exploring their natural products.

Authors:  Azam Moradi; Mohammad Yaghoubi-Avini; Joachim Wink
Journal:  Arch Microbiol       Date:  2022-01-07       Impact factor: 2.552

Review 3.  Plasmalogens and Photooxidative Stress Signaling in Myxobacteria, and How it Unmasked CarF/TMEM189 as the Δ1'-Desaturase PEDS1 for Human Plasmalogen Biosynthesis.

Authors:  S Padmanabhan; Antonio J Monera-Girona; Elena Pajares-Martínez; Eva Bastida-Martínez; Irene Del Rey Navalón; Ricardo Pérez-Castaño; María Luisa Galbis-Martínez; Marta Fontes; Montserrat Elías-Arnanz
Journal:  Front Cell Dev Biol       Date:  2022-05-11

4.  Methods for Identifying Microbial Natural Product Compounds that Target Kinetoplastid RNA Structural Motifs by Homology and De Novo Modeled 18S rRNA.

Authors:  Harrison Ndung'u Mwangi; Edward Kirwa Muge; Peter Waiganjo Wagacha; Albert Ndakala; Francis Jackim Mulaa
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

5.  Identification of a solo acylhomoserine lactone synthase from the myxobacterium Archangium gephyra.

Authors:  Hanan Albataineh; Maya Duke; Sandeep K Misra; Joshua S Sharp; D Cole Stevens
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

6.  The Sandarazols are Cryptic and Structurally Unique Plasmid-Encoded Toxins from a Rare Myxobacterium*.

Authors:  Fabian Panter; Chantal D Bader; Rolf Müller
Journal:  Angew Chem Int Ed Engl       Date:  2021-03-04       Impact factor: 15.336

7.  Strong Antibiotic Activity of the Myxocoumarin Scaffold in vitro and in vivo.

Authors:  Gesa Hertrampf; Kalina Kusserow; Sandra Vojnovic; Aleksandar Pavic; Jonas I Müller; Jasmina Nikodinovic-Runic; Tobias A M Gulder
Journal:  Chemistry       Date:  2022-04-26       Impact factor: 5.020

8.  Enhancing the production of amphotericin B by Strepyomyces nodosus in a 50-ton bioreactor based on comparative genomic analysis.

Authors:  Kai Huang; Bo Zhang; Yu Chen; Zhe-Ming Wu; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  3 Biotech       Date:  2021-05-27       Impact factor: 2.893

9.  Assessment of Evolutionary Relationships for Prioritization of Myxobacteria for Natural Product Discovery.

Authors:  Andrew Ahearne; Hanan Albataineh; Scot E Dowd; D Cole Stevens
Journal:  Microorganisms       Date:  2021-06-24

10.  Large-scale computational discovery and analysis of virus-derived microbial nanocompartments.

Authors:  Michael P Andreas; Tobias W Giessen
Journal:  Nat Commun       Date:  2021-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.